January 1, 2025, Taipei — YC Biotech Co., Ltd. (hereinafter referred to as “YC Biotech”) and Taipei Medical University (hereinafter referred to as “TMU”) officially announced today that they will jointly execute the “Global Market Analysis of Biomedical Implants” industry-academia collaboration project from January 1, 2025, to December 31, 2025. This project aims to integrate industry and academic resources to conduct an in-depth exploration of the current status and future trends of the global biomedical implants market, providing key strategies and insights for Taiwan’s biotech industry to expand into international markets.
With the global aging population and the rapid development of medical technology, the demand for biomedical implants continues to rise, making it a significant growth driver in the global medical industry. As a startup in Taiwan’s biotech sector, YC Biotech has maintained a deep industry-academia collaboration with TMU. Taipei Medical University, renowned for its outstanding medical research, will combine industry practices with academic research capabilities through this collaboration, injecting new momentum into Taiwan’s biotech industry.
Project Focus and Objectives
The “Global Market Analysis of Biomedical Implants” project will be conducted by a professional team at TMU commissioned by YC Biotech. The project will comprehensively analyze the global biomedical implants market, covering aspects such as market size, technological advancements, competitive landscape, regulatory environment, and future trends. The results of the project will serve as a reference for both the industry and academia, helping Taiwan’s biotech companies grasp international market dynamics and providing a scientific basis for relevant policy-making.
YC Biotech stated, “We are honored to collaborate with Taipei Medical University. This project is not only a model of industry-academia collaboration but also a significant step for Taiwan’s biotech industry toward internationalization. Through this collaboration, we look forward to creating more opportunities for Taiwan’s biomedical implants industry and contributing to the
development of global medical technology.”
TMU noted, “TMU has always actively promoted industry-academia collaboration. This partnership with YC Biotech will further strengthen the connection between academic research and industrial applications. We believe that through the joint efforts of both parties, this collaboration will bring breakthrough developments to Taiwan’s biotech industry and enhance its international competitiveness.”
